Indo Us Biotech Limited has informed the Exchange about Action(s) initiated_Receipt of Summons from the Directorate of Enforcement (ED) under PMLA. Summon dated November 20, 2025 (received in mail dated Nov 27, 2025)
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has disclosed that it received a summons from the Directorate of Enforcement (ED) under the Prevention of Money Laundering Act (PMLA). The summon is dated November 20, 2025, and the company received it via mail on November 27, 2025. The ED has initiated action against the company, though the exact nature of the alleged offence and the amount involved have not been disclosed in the filing. This marks the start of an official investigation by India's financial crime investigation agency. Shareholders should watch for further disclosures about the substance of the summons and the company's response.
This is a negative development that could create uncertainty around the stock, as ED investigations under PMLA can lead to penalties, asset attachment, or further legal action. Investors should monitor upcoming filings for more details on the allegations before making decisions.